Skip to main content
. Author manuscript; available in PMC: 2014 Jun 10.
Published in final edited form as: Crit Rev Immunol. 2013;33(4):361–378. doi: 10.1615/critrevimmunol.2013007444

FIGURE 3.

FIGURE 3

Effect of CD40 agonist on survival of T. gondii-infected animals. (A) Wild-type mice were infected perorally with T. gondii cysts. Beginning on either day 3 or week 5 post-infection, mice were treated with CD40 agonist antibody (FGK115) or PBS twice weekly for a 2-week period. (B) Mice were monitored for survival, and data represent two experiments with at least 6 mice per group.